LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.031623
 52.27 770.25 1599 7058 0.2265 0.2568
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 54.49 770.25 1662 7555 0.2200 0.2630
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 54.49 770.25 1658 7555 0.2194 0.2620
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 56.71 770.25 1711 8001 0.2138 0.2666
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 56.71 770.25 1703 8001 0.2128 0.2649
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 58.94 770.25 1753 8444 0.2076 0.2688
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 58.94 770.25 1721 8444 0.2038 0.2620
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 61.16 770.25 1803 8892 0.2028 0.2725
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 61.16 770.25 1721 8892 0.1935 0.2558
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 63.39 770.25 1839 9326 0.1972 0.2736
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 63.39 770.25 1755 9326 0.1882 0.2572
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 65.61 770.25 1853 9736 0.1903 0.2711
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 65.61 770.25 1780 9736 0.1828 0.2572
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 67.83 770.25 1886 10078 0.1871 0.2730
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 67.83 770.25 1797 10078 0.1783 0.2565
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 70.05 770.25 1898 10413 0.1823 0.2713
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 70.05 770.25 1815 10413 0.1743 0.2563
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 72.27 770.25 1915 10730 0.1785 0.2708
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 72.27 770.25 1826 10730 0.1702 0.2550
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 74.50 770.25 1975 10991 0.1797 0.2783
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 74.50 770.25 1851 10991 0.1684 0.2569
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 76.75 770.25 1970 11262 0.1749 0.2746
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 76.75 770.25 1868 11262 0.1659 0.2572
MN20160304_L02
F10
MCF 10A-H2B-mCherry Trametinib
0.031623
 78.98 770.25 2000 11518 0.1736 0.2770
MN20160304_L02
C04
MCF 10A-H2B-mCherry Trametinib
0.031623
 78.98 770.25 1925 11518 0.1671 0.2646
MN20160304_L02
F10